Ramazan Acar, Semra Paydaş, Murat Yıldırım, Emrah Kılıçarslan, Ugur Sahın, Ali Dogan, Deniz C Guven, Omer Ekıncı, Mesut Tıglıoglu, Isıl Erdogan, Tayfun Elıbol, Halil Kızıloz, Musa B Aykan, Selim Sayın, Kursat Kaptan, Ender Soydan, Ayla Gokmen, Ramazan Esen, Ibrahim Barısta, Murat Albayrak, Ismail Erturk, Birol Yıldız, Gulsema Y Keskın, Meltem Aylı, Nuri Karadurmus
INTRODUCTION AND AIM: Primary mediastinal B-cell lymphomas (PMBL) are aggressive B- cell lymphomas. Although the initial treatment models vary in PMBL, appropriate treatment methods are not known. We aim to show real-life data on health outcomes in adult patients with PMBL who received various type of chemoimmunotherapies in Turkey. METHOD: We analyzed the data of 61 patients who received treatments for PMBL from 2010 to 2020. The overall response rate (ORR), overall survival (OS) and progression-free survival (PFS) of the patients were evaluated...
April 2023: Journal of Cancer Research and Therapeutics